首页|益血生胶囊联合蛋白琥珀酸铁治疗妊娠期缺铁性贫血的疗效及对患者铁代谢指标的影响

益血生胶囊联合蛋白琥珀酸铁治疗妊娠期缺铁性贫血的疗效及对患者铁代谢指标的影响

扫码查看
目的 探讨益血生胶囊联合蛋白琥珀酸铁在妊娠期缺铁性贫血(IDA)中的应用价值.方法 选择 2023 年 1月—2024 年3 月岷县妇幼保健院收治的 120 例妊娠期IDA患者为研究对象,按随机数字表法将其分为对照组和观察组,每组 60 例.对照组采用蛋白琥珀酸铁治疗,观察组在对照组基础上采用益血生胶囊治疗,两组均持续治疗 3 个月.比较两组的临床疗效、铁代谢指标、血常规指标及不良反应发生情况.结果 观察组治疗总有效率为 93.33%,高于对照组的 80.00%,差异有统计学意义(P﹤0.05).治疗后,观察组总铁结合力水平低于对照组,血清铁蛋白水平高于对照组,组间差异有统计学意义(P﹤0.05);观察组红细胞总量、血红蛋白水平均高于对照组,组间差异有统计学意义(P﹤0.05).两组不良反应发生率比较,差异无统计学意义(P﹥0.05).结论 蛋白琥珀酸铁联合益血生胶囊治疗妊娠期IDA的疗效确切,能够有效改善患者的铁代谢指标及血红蛋白水平,且较为安全.
Therapeutic Effect of Yixuesheng Capsule Combined with Iron Protein Succinate on Iron Deficiency Anemia During Pregnancy and Its Influence on Iron Metabolism Indicators in Patients
Objective To explore the application value of Yixuesheng capsule combined with iron protein succinate in iron deficiency anemia(IDA)during pregnancy.Methods A total of 120 patients with IDA during pregnancy admitted to Minxian Maternal and Child Health Hospital from January 2023 to March 2024 were selected as the research objects,and were divided into a control group and an observation group according to random number table method,with 60 cases in each group.The control group was treated with iron protein succinate,and the observation group was treated with Yixuesheng capsule on the basis of the control group,both groups received continuous treatment for 3 months.The clinical efficacy,iron metabolism indicators,blood routine indicators and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 93.33%,which was higher than 80.00%of the control group,and the difference was statistically significant(P﹤0.05).After treatment,the total iron binding capacity of observation group was lower than that of control group,and the serum ferritin level was higher than that of the control group,and the differences between the groups were statistically significant(P﹤ 0.05);the total red blood cell count and hemoglobin level in the observation group were higher than those in the control group,and the differences between the groups were statistically significant(P﹤0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P﹥0.05).Conclusion Iron protein succinate combined with Yixuesheng capsule in the treatment of IDA in pregnancy is effective,can effectively improve the iron metabolism indicators and hemoglobin levels of patients,and is relatively safe.

Iron deficiency anemiaDuring pregnancyIron protein succinateYixuesheng capsuleClinical efficacyIron metabolism

赵小燕

展开 >

岷县妇幼保健院妇产科,甘肃 定西 748400

缺铁性贫血 妊娠期 蛋白琥珀酸铁 益血生胶囊 临床疗效 铁代谢

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(19)